CinCor Pharma Inc (CINC) Financials

$29.06

$0.00 (0.00%)

As on 03-Mar-2023 09:30EDT

Market cap

$1,272 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	82.53	42.51	21.13	5.14	--	--
Operating Profit (EBIT)	-82.53	-42.51	-21.13	-5.14	--	--
Other Income	-1.45	-7.86	--	--	--	--
Profit before Tax	-88.09	-50.37	-22.30	-5.04	--	--
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-88.09	-50.37	-22.30	-5.04	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-88.09	-50.37	-22.30	-5.04	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	518.94	-63.72	-27.26	-4.98	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	188.27	47.17	15.18	--	--
Current Liabilities	10.18	16.55	6.89	1.72	--	--
Total Liabilities	539.30	141.11	26.80	11.92	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	0.10	--	--	--	--	--
Current Assets	529.02	141.11	26.80	11.92	--	--
Total Assets	539.30	141.11	26.80	11.92	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	518.84	124.56	19.91	10.20	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-30.85	-17.40	-4.43	--	--
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	141.37	31.99	15.91	--	--
Net Cash Inflow / Outflow	--	110.53	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-16.24	-25.18	--	--	--	--
Cash EPS ($)	--	-25.18	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-15.42	--	--	--	--
Free Cash Flow per Share ($)	--	-15.42	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	110.72	138.30	--	--	--
ROE (%)	-21.10	110.72	138.30	--	--	--
ROA (%)	-25.24	-60.00	-115.17	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	6,082.28	640.94	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-449.59	-138.43	-311.26	--	--	--
Net Profit Growth (%)	-228.29	-125.89	-342.86	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	156.50	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.02	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.10	--	--	--	--	--
Close Price ($)	32.82	--	--	--	--	--
High Price ($)	43.15	--	--	--	--	--
Low Price ($)	13.00	--	--	--	--	--
Market Cap ($ Cr)	1,271.79	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	51.96	8.53	3.89	6.92	--	--
Quick Ratio	51.96	--	--	--	--	--
Interest Coverage	-53.74	-2,327.48	-575.19	-50.51	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.